SK279105B6 - Oleandromycínoximy, spôsob ich prípravy a použitie - Google Patents
Oleandromycínoximy, spôsob ich prípravy a použitie Download PDFInfo
- Publication number
- SK279105B6 SK279105B6 SK768-91A SK76891A SK279105B6 SK 279105 B6 SK279105 B6 SK 279105B6 SK 76891 A SK76891 A SK 76891A SK 279105 B6 SK279105 B6 SK 279105B6
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- single bond
- line
- oleandromycin
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 14
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 125000003700 epoxy group Chemical group 0.000 claims abstract description 4
- 239000004599 antimicrobial Substances 0.000 claims abstract description 3
- 150000002923 oximes Chemical class 0.000 claims description 19
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract description 14
- 238000006243 chemical reaction Methods 0.000 abstract description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- 150000002596 lactones Chemical class 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 238000006146 oximation reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| YU00556/90A YU55690A (en) | 1990-03-21 | 1990-03-21 | Process for preparing oleandomycin oxime |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK279105B6 true SK279105B6 (sk) | 1998-06-03 |
Family
ID=25550446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK768-91A SK279105B6 (sk) | 1990-03-21 | 1991-03-21 | Oleandromycínoximy, spôsob ich prípravy a použitie |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5268462A (da) |
| EP (1) | EP0448035B1 (da) |
| JP (1) | JP2763972B2 (da) |
| CN (1) | CN1033645C (da) |
| AT (1) | ATE132872T1 (da) |
| BG (1) | BG60682B1 (da) |
| CA (1) | CA2038629C (da) |
| CZ (1) | CZ279898B6 (da) |
| DE (1) | DE69116188T2 (da) |
| DK (1) | DK0448035T3 (da) |
| ES (1) | ES2084721T3 (da) |
| GR (1) | GR3019113T3 (da) |
| HR (1) | HRP920482B1 (da) |
| HU (2) | HU207868B (da) |
| PL (1) | PL166395B1 (da) |
| RO (1) | RO111769B1 (da) |
| RU (1) | RU2021281C1 (da) |
| SI (1) | SI9010556B (da) |
| SK (1) | SK279105B6 (da) |
| UA (1) | UA26903C2 (da) |
| YU (1) | YU55690A (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP931480B1 (en) * | 1993-12-08 | 1997-08-31 | Sour Pliva | 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A |
| RU2256665C1 (ru) * | 2004-01-29 | 2005-07-20 | Открытое акционерное общество Акционерное Курганское общество медицинских препаратов и изделий "Синтез" | Способ получения оксима эритромицина |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2275459A2 (fr) * | 1974-06-21 | 1976-01-16 | Aries Robert | Nouveau derive de la rifamycine |
| US4063014A (en) * | 1975-06-12 | 1977-12-13 | Abbott Laboratories | 4"-O-sulfonyl erythromycin-9-O-oxime derivatives |
| US4069379A (en) * | 1976-07-08 | 1978-01-17 | Pfizer Inc. | Semi-synthetic oleandomycins |
| US4180654A (en) * | 1978-01-03 | 1979-12-25 | Pfizer Inc. | 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate |
| US4336368A (en) * | 1981-04-20 | 1982-06-22 | Pfizer Inc. | 4 Deoxy-4-methylene oleandomycin and derivatives thereof |
| US4429116A (en) * | 1982-12-27 | 1984-01-31 | Pfizer Inc. | Alkylated oleandomycin containing compounds |
| JPS61103890A (ja) * | 1984-10-26 | 1986-05-22 | Taisho Pharmaceut Co Ltd | ６−０−メチルエリスロマイシンａ誘導体 |
-
1990
- 1990-03-21 SI SI9010556A patent/SI9010556B/sl not_active IP Right Cessation
- 1990-03-21 YU YU00556/90A patent/YU55690A/xx unknown
-
1991
- 1991-03-14 US US07/669,728 patent/US5268462A/en not_active Expired - Lifetime
- 1991-03-19 AT AT91104231T patent/ATE132872T1/de not_active IP Right Cessation
- 1991-03-19 CA CA002038629A patent/CA2038629C/en not_active Expired - Fee Related
- 1991-03-19 DE DE69116188T patent/DE69116188T2/de not_active Expired - Fee Related
- 1991-03-19 DK DK91104231.5T patent/DK0448035T3/da active
- 1991-03-19 ES ES91104231T patent/ES2084721T3/es not_active Expired - Lifetime
- 1991-03-19 EP EP91104231A patent/EP0448035B1/en not_active Expired - Lifetime
- 1991-03-20 RO RO147197A patent/RO111769B1/ro unknown
- 1991-03-20 UA UA4894988A patent/UA26903C2/uk unknown
- 1991-03-20 HU HU91935A patent/HU207868B/hu not_active IP Right Cessation
- 1991-03-20 JP JP3130738A patent/JP2763972B2/ja not_active Expired - Fee Related
- 1991-03-20 BG BG94079A patent/BG60682B1/bg unknown
- 1991-03-20 CN CN91101710A patent/CN1033645C/zh not_active Expired - Fee Related
- 1991-03-20 PL PL91289507A patent/PL166395B1/pl not_active IP Right Cessation
- 1991-03-20 RU SU914894988A patent/RU2021281C1/ru not_active IP Right Cessation
- 1991-03-21 SK SK768-91A patent/SK279105B6/sk unknown
- 1991-03-21 CZ CS91768A patent/CZ279898B6/cs not_active IP Right Cessation
-
1992
- 1992-09-25 HR HRP-556/90A patent/HRP920482B1/xx not_active IP Right Cessation
-
1995
- 1995-06-30 HU HU95P/P00609P patent/HU211574A9/hu unknown
-
1996
- 1996-02-28 GR GR960400535T patent/GR3019113T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT56848A (en) | 1991-10-28 |
| ATE132872T1 (de) | 1996-01-15 |
| GR3019113T3 (en) | 1996-05-31 |
| CN1054979A (zh) | 1991-10-02 |
| RU2021281C1 (ru) | 1994-10-15 |
| SI9010556B (sl) | 1998-10-31 |
| BG60682B1 (bg) | 1995-12-29 |
| CA2038629A1 (en) | 1991-09-22 |
| JPH04234896A (ja) | 1992-08-24 |
| SI9010556A (sl) | 1998-04-30 |
| CA2038629C (en) | 1996-09-10 |
| JP2763972B2 (ja) | 1998-06-11 |
| PL166395B1 (pl) | 1995-05-31 |
| RO111769B1 (ro) | 1997-01-30 |
| US5268462A (en) | 1993-12-07 |
| BG94079A (bg) | 1993-12-24 |
| CS9100768A2 (en) | 1991-11-12 |
| HU211574A9 (en) | 1995-12-28 |
| EP0448035A1 (en) | 1991-09-25 |
| DE69116188T2 (de) | 1996-09-05 |
| UA26903C2 (uk) | 1999-12-29 |
| HRP920482B1 (en) | 1998-12-31 |
| PL289507A1 (en) | 1992-03-09 |
| CZ279898B6 (cs) | 1995-08-16 |
| DK0448035T3 (da) | 1996-05-20 |
| HRP920482A2 (en) | 1994-08-31 |
| DE69116188D1 (de) | 1996-02-22 |
| YU55690A (en) | 1990-12-31 |
| ES2084721T3 (es) | 1996-05-16 |
| HU207868B (en) | 1993-06-28 |
| CN1033645C (zh) | 1996-12-25 |
| EP0448035B1 (en) | 1996-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS582960B2 (ja) | 新規なプソイドサッカライド類の製造方法 | |
| US4117221A (en) | Aminoacyl derivatives of aminoglycoside antibiotics | |
| CA2137395C (en) | 9a-n-(n'-carbamoyl) and 9a-n-(n' - thiocarbamoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin a | |
| CA1129852A (en) | Aminoglycoside derivatives | |
| US4273923A (en) | Process for preparing aminoglycoside derivatives | |
| SK279105B6 (sk) | Oleandromycínoximy, spôsob ich prípravy a použitie | |
| US4476298A (en) | Erythromycin A derivatives | |
| KOBREHEL et al. | SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF Ö-METHYLAZITHROMYCIN DERIVATIVES | |
| US4330673A (en) | Process for producing 3-O-demethylaminoglycoside and novel 3-O-demethylfortimicin derivatives | |
| GB2068366A (en) | A paromomycin derivative | |
| EP0508725A1 (en) | Novel process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers | |
| EP0508726A1 (en) | Novel process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives | |
| US4205070A (en) | 6'N-Alkyl- and 6',6'-di-N-alkyl derivatives of fortimicins A and B | |
| SI9700267A (sl) | 9-N-etenil derivati 9(S)-eritromicilamina | |
| US3647779A (en) | Kasugamycin substituted antibacterial agents | |
| Nishimura et al. | A synthesis of 3', 4'-dideoxykanamycin B. | |
| Matsushima et al. | Chemical transformation of seldomycin 5 into 3'-episeldomycin 5 and its antibacterial activity. | |
| US4208407A (en) | 5-Deoxyfortimicin A, 2,5-dideoxyfortimicin A and the corresponding 4-N-acyl and alkyl fortimicin B derivatives thereof and intermediates therefor | |
| MORIMOTO et al. | CHEMICAL MODIFICATION OF ERYTHROMYCINS V. SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF 4''-O-METHYL DERIVATIVES OF ERYTHROMYCIN A 11, 12-CYCLIC CARBONATE | |
| KR790001981B1 (ko) | 디아미노 사이클리톨 유도체의 제조방법 | |
| JP3215732B2 (ja) | 耐性菌に有効なジベカシン誘導体またはアルベカシン誘導体とそれらの製造法 | |
| DK147075B (da) | Analogifremgangsmaade til fremstilling af kanamycin a eller kanamycin b derivater eller salte deraf | |
| EP0515141A1 (en) | Novel process for the preparation of 8A-aza-8A-homoerythromycin cyclic lactams | |
| GB2068367A (en) | A paromomycin derivative | |
| Suami et al. | Modification of aminocyclitol antibiotics. 8. Preparation of 5, 6"-dideoxykanamycin B. |